Creating a Sustainable Future through PHACT™ PHA
Company & History
How We Started
The core technology platforms for CJ Biomaterials date back to 2010, when they were inaugurated as part of a push by the CJ Group into biotechnology. In 2016, CJ CheilJedang acquired Metabolix and its PHA (polyhydroxyalkanoate) technology. CJ CheilJedang started to further develop the technology and had the capacity to make it available in quantities that could satisfy industry demand.
Shortly after the launch of CJ Biomaterials in 2022, we inaugurated our new PHA production facility in Pasuruan, Indonesia, and introduced our first product, PHACT™ A1000P. This revolutionary amorphous PHA is certified biodegradable under industrial compost, soil and marine environments. It is also considered home compostable, meaning it does not require specialized equipment or elevated temperatures to degrade fully.
Our Impact
Creating Materials That Move Industries Beyond Traditional Plastics
CJ Biomaterials develops meaningful solutions that positively affect our planet and human health and well-being by addressing the challenges posed by fossil fuel-based technologies, including plastic waste. CJ Biomaterials invents and manufactures bio-based chemicals and biopolymers as part of a long-term vision to create a more sustainable future by offering circular solutions that replace many non-recyclable, non-reusable and fossil fuel-based plastics and chemicals.
“We create sustainable values to save lives and protect the earth”
CJ Biomaterials Mission Statement
Our Journey
From Innovation to Global Production
CJ Biomaterials’ journey spans over a decade of biotechnology innovation, strategic acquisitions, and large-scale production, culminating in the launch of certified PHA solutions.
-
2010
Biotechnology Foundations
CJ Group established its core biomaterials technology platforms, marking its entry into biotechnology and laying the foundation for future PHA development.
-
2016
Metabolix Acquisition
CJ acquires Metabolix and its PHA technology, expanding its capabilities in biopolymers and enabling scalable production to meet industry demand.
-
2020 2021
Indonesia Plant Construction
CJ begins construction of its PHA production facility in Pasuruan, Indonesia, designed to support large-scale manufacturing (5,000 tons/year).
-
2022
Launch & Commercialization
CJ Biomaterials is officially launched, the Indonesia plant becomes operational, and the company introduces its first product, PHACT™ A1000P, a certified biodegradable material suitable for industrial compost, soil, and marine environments.
Ready to learn more about how PHACT™ PHA can be used in your products?
FAQs
Frequently Asked Questions
Find answers to common questions about PHA materials, applications, performance, and sustainability.
Explore PHACT™ PHA for Your Applications
Our technical team can help evaluate materials, performance requirements, and sustainability targets for your application.
CJ Biomaterials is a business unit of CJ CheilJedang, a global lifestyle and biotechnology company.
PHACT™ PHA is produced through a natural microbial fermentation process.
Biodegradable biopolymers like PHA are highly versatile and are increasingly adopted across a wide range of industries looking to improve their sustainability footprint including packaging, food service, and cosmetics.
Replacing traditional plastics with biopolymers offers critical environmental and economic benefits including fossil fuel independence, lower carbon footprint, and versatility in its end of life.
Biodegradable materials are a vital piece of the puzzle in solving the global plastic pollution crisis.